MLTX
Price
$9.52
Change
+$0.06 (+0.63%)
Updated
Oct 24 closing price
Capitalization
604.53M
24 days until earnings call
Intraday Buy/Sell Signals
SYRE
Price
$23.37
Change
+$1.00 (+4.47%)
Updated
Oct 24 closing price
Capitalization
1.81B
12 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

MLTX vs SYRE

Header iconMLTX vs SYRE Comparison
Open Charts MLTX vs SYREBanner chart's image
MoonLake Immunotherapeutics
Price$9.52
Change+$0.06 (+0.63%)
Volume$1.66M
Capitalization604.53M
Spyre Therapeutics
Price$23.37
Change+$1.00 (+4.47%)
Volume$700.7K
Capitalization1.81B
MLTX vs SYRE Comparison Chart in %
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MLTX vs. SYRE commentary
Oct 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLTX is a Hold and SYRE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 25, 2025
Stock price -- (MLTX: $9.52 vs. SYRE: $23.37)
Brand notoriety: MLTX and SYRE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLTX: 29% vs. SYRE: 78%
Market capitalization -- MLTX: $604.53M vs. SYRE: $1.81B
MLTX [@Biotechnology] is valued at $604.53M. SYRE’s [@Biotechnology] market capitalization is $1.81B. The market cap for tickers in the [@Biotechnology] industry ranges from $108.04B to $0. The average market capitalization across the [@Biotechnology] industry is $2.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLTX’s FA Score shows that 0 FA rating(s) are green whileSYRE’s FA Score has 0 green FA rating(s).

  • MLTX’s FA Score: 0 green, 5 red.
  • SYRE’s FA Score: 0 green, 5 red.
According to our system of comparison, SYRE is a better buy in the long-term than MLTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLTX’s TA Score shows that 5 TA indicator(s) are bullish while SYRE’s TA Score has 7 bullish TA indicator(s).

  • MLTX’s TA Score: 5 bullish, 5 bearish.
  • SYRE’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, SYRE is a better buy in the short-term than MLTX.

Price Growth

MLTX (@Biotechnology) experienced а +4.39% price change this week, while SYRE (@Biotechnology) price change was +4.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.97%. For the same industry, the average monthly price growth was +11.13%, and the average quarterly price growth was +63.98%.

Reported Earning Dates

MLTX is expected to report earnings on Nov 18, 2025.

SYRE is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+0.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYRE($1.81B) has a higher market cap than MLTX($605M). SYRE YTD gains are higher at: 0.387 vs. MLTX (-82.419). MLTX has higher annual earnings (EBITDA): -196.98M vs. SYRE (-222.15M). SYRE has more cash in the bank: 527M vs. MLTX (425M). SYRE has less debt than MLTX: SYRE (0) vs MLTX (75.8M). MLTX (0) and SYRE (0) have equivalent revenues.
MLTXSYREMLTX / SYRE
Capitalization605M1.81B33%
EBITDA-196.98M-222.15M89%
Gain YTD-82.4190.387-21,319%
P/E RatioN/A1.72-
Revenue00-
Total Cash425M527M81%
Total Debt75.8M0-
FUNDAMENTALS RATINGS
SYRE: Fundamental Ratings
SYRE
OUTLOOK RATING
1..100
27
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
82
SEASONALITY SCORE
1..100
23

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MLTXSYRE
RSI
ODDS (%)
Bullish Trend 2 days ago
50%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
53%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
58%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 13 days ago
82%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 9 days ago
72%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CAPEX2956.75N/A
N/A
Eaton Vance Tx-Mgd Growth 1.0
INTIX13.65N/A
N/A
Voya International Index Port S
ITHRX54.31N/A
N/A
Hartford Capital Appreciation R3
TLATX12.69N/A
N/A
Transamerica Large Core ESG I3
PAHUX7.29N/A
N/A
PGIM Jennison NextGeneration Glb Opps Z

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been closely correlated with KALA. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if MLTX jumps, then KALA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+0.63%
KALA - MLTX
88%
Closely correlated
+1.75%
IOBT - MLTX
76%
Closely correlated
N/A
NEVPF - MLTX
70%
Closely correlated
N/A
XNCR - MLTX
50%
Loosely correlated
+7.05%
NUVL - MLTX
48%
Loosely correlated
+2.75%
More